DR. ERICA PARKER

Dr. Parker joined the Hergenrother lab in February 2017 after receiving her Ph.D. in Chemistry at Baylor University. Her graduate studies in the laboratory of Prof. Kevin G. Pinney focused on the design and synthesis of small-molecule, thiosemicarbazone based inhibitors of cathepsin L as potential anti-metastatic agents.

Publications:

 

Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L

Parker, E. N.; Odutola, S. O.; Wang, Y.; Strecker, T. E.; Mukherjee, R.; Shi, Z.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.  

Bioorg. Med. Chem. Lett. 201727, 1304-1310.

 

Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L

Parker, E. N.; Song, J.; Kumar, G. D. K.; Odutola, S. O.; Chavarria, G. E.; Charlton-Sevcik, A. K.; Strecker, T. E.; Barnes, A. L.; Sudhan, D. R.; Wittenborn, T. R.; Siemann, D. W.; Horsman, M. R.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.

Bioorg. Med. Chem. 201521, 6974-6992.

 

Initial evaluation of the antitumor activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L

Chavarria, G. E; Horsman, M. R.; Arispe, W. M.; Kumar, G. D. K., Chen. S.-E.; Strecker, T. E.; Parker, E. N.; Chaplin, D. J.; Pinney, K. G.; Trawick, M. L.

Eur. J. Med. Chem201258, 568-572.

 

A practical and highly efficient hydroacylation reaction of azodicarboxylates with aldehydes in water

Zhang, Q.*; Parker, E.*; Headley, A. D.; Ni, B.

Synlett 201016, 2453-2456. *equal authorship

 

Design and Synthesis of Bistereogenic Chiral Ionic Liquids and Their Use as Solvents for Asymmetric Baylis-Hillman Reactions

Garre, S.; Parker, E.; Ni, B.; Headley, A. D.

Org. Biomol. Chem. 2008, 6, 3041-3043.

Please reload